how many glp 1 drugs are there Poll: in 8 Adults Say They Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Are Difficult to Afford Overview of GLP-1s
Description
Risk of bias was assessed using an adapted Quality Assessment Tool for In Vitro Studies (QUIN) tool
Supports overall daily wellness
Explore the mechanisms, clinical applications, and future opportunities of GLP-1 receptor agonists in drug development and disease management.
Those with obesity might have other serious chronic health conditions, including diabetes and high blood pressure, which are leading risk factors for heart disease and stroke
GLP-1RAs reduce events linked to atherogenic cardiovascular disease (especially ischemic stroke) and also renal outcomes (FLOW trial with semaglutide), with a limited effect on heart failure
In 2025 we saw label expansions for semaglutide and tirzepatide, underscoring a trend toward whole-body health
